Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yuki Oda, Makito Miyake, Nobutaka Nishimura, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Open Exploration Publishing Inc. 2026-04-01
Schriftenreihe:	Exploration of Targeted Anti-tumor Therapy
Schlagworte:	bacillus calmette–guérin (bcg) therapy non-muscle invasive bladder cancer urinary immune profiling urinary microbiome dynamics firmicutes/bacteroidetes ratio progression-free survival
Online-Zugang:	https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!